Hormonal fluctuations in rodent models using 4-vinylcyclohexene diepoxide: A systematic review and meta-analysis
- PMID: 39826372
- DOI: 10.1016/j.yhbeh.2025.105680
Hormonal fluctuations in rodent models using 4-vinylcyclohexene diepoxide: A systematic review and meta-analysis
Abstract
An animal model of 4-vinylcyclohexene diepoxide (VCD)-induced premature ovarian failure was developed to mimic menopause; this model has been used in various field studies. However, detailed reports on the rodent model using VCD are lacking, and the animal species used, administration methods, and hormonal fluctuations in the creation of the VCD model have not been comprehensively elucidated. The aim of this study was to systematically review these aspects of the rodent model using VCD and elucidate its characteristics. Thirty-two studies were extracted; rats and mice (66 %/44 %) are the most commonly used animal species. In most of the studies involving mice, a dose of 160 mg/kg was administered, whereas in most rat studies, doses of 80 mg/kg and 160 mg/kg were administered. On most mice studies (70 %), the most frequently applied dosage duration was 15 days. In most rat studies (63 %), the most frequently applied duration was 25 days, followed by 14 and 15 days in 30 % of the studies. Meta-analysis indicated that the mouse model using VCD simulates significant hormonal changes, such as estradiol (E2), anti-Müllerian hormone (AMH), and follicle stimulating hormone (FSH) changes. In conclusion, although the VCD model has demonstrated significant promise in replicating menopausal hormonal conditions, further systematic studies are required to fully understand its potential applications and refine its methodologies. This comprehensive review of existing literature highlights the need for continued research to expand the use of the VCD model in diverse medical fields.
Keywords: Female hormonal; Rodent model; Systematic review; Vinylcyclohexene; meta-analysis.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no competing interests.
Similar articles
-
Huyang yangkun formula protects against 4-Vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats via the Hippo-JAK2/STAT3 signaling pathway.Biomed Pharmacother. 2019 Aug;116:109008. doi: 10.1016/j.biopha.2019.109008. Epub 2019 May 29. Biomed Pharmacother. 2019. PMID: 31152926
-
Hormonal changes and increased anxiety-like behavior in a perimenopause-animal model induced by 4-vinylcyclohexene diepoxide (VCD) in female rats.Psychoneuroendocrinology. 2014 Nov;49:130-40. doi: 10.1016/j.psyneuen.2014.06.019. Epub 2014 Jul 12. Psychoneuroendocrinology. 2014. PMID: 25080405
-
Steroidogenic capacity of residual ovarian tissue in 4-vinylcyclohexene diepoxide-treated mice.Biol Reprod. 2009 Feb;80(2):328-36. doi: 10.1095/biolreprod.108.070359. Epub 2008 Oct 1. Biol Reprod. 2009. PMID: 18829706 Free PMC article.
-
4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity.Syst Biol Reprod Med. 2012 Feb;58(1):57-62. doi: 10.3109/19396368.2011.648820. Syst Biol Reprod Med. 2012. PMID: 22239082 Free PMC article. Review.
-
Accelerated ovarian failure: a novel, chemically induced animal model of menopause.Brain Res. 2011 Mar 16;1379:176-87. doi: 10.1016/j.brainres.2010.12.064. Epub 2011 Jan 4. Brain Res. 2011. PMID: 21211517 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical